Medicine Description palonoflat 0.25 mg
palonoflat 0.25 mg vial 5 ml is a medication that functions as a selective serotonin 5-HT3 receptor antagonist. It specifically targets and binds to the 5-HT3 receptors located in the central nervous system, particularly in the area postrema of the brain and the gastrointestinal tract. By blocking the action of serotonin, which is released during chemotherapy or radiation therapy, palonoflat prevents the initiation of the vomiting reflex. This mechanism is particularly effective in the context of chemotherapeutic agents that induce nausea and vomiting, allowing patients to better tolerate their treatment by minimizing these debilitating side effects.
Indications and Uses of palonoflat 0.25 mg vial 5 ml
- Prevention of acute nausea and vomiting associated with highly emetogenic cancer chemotherapy
- Prevention of delayed nausea and vomiting associated with moderately emetogenic cancer chemotherapy
- Prevention of nausea and vomiting induced by radiation therapy
Side Effects of palonoflat 0.25 mg vial 5 ml
- Headache
- Constipation
- Dizziness
- Fatigue
- Abdominal pain
Storage and Handling
Store palonoflat at controlled room temperature, away from light and moisture. Do not freeze. Ensure that it is kept out of reach of children.
Patient Advice and Precautions
Always inform your healthcare provider about any other medications you are taking to avoid potential interactions.Notify your physician if you experience any severe side effects, especially persistent headache or abdominal pain.It is important to follow your healthcare provider's instructions regarding the timing of administration before chemotherapy or radiation treatment.